TY  - GEN
AU  - Delmas,P D
AU  - Benhamou,C L
AU  - Man,Z
AU  - Tlustochowicz,W
AU  - Matzkin,E
AU  - Eusebio,R
AU  - Zanchetta,J
AU  - Olszynski,W P
AU  - Recker,R R
AU  - McClung,M R
TI  - Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results
SN  - 0937-941X
PY  - 2009///0113
KW  - Absorptiometry, Photon
KW  - Administration, Oral
KW  - Aged
KW  - Bone Density
KW  - drug effects
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Etidronic Acid
KW  - Female
KW  - Femur Neck
KW  - Humans
KW  - Lumbar Vertebrae
KW  - Middle Aged
KW  - Osteoporosis, Postmenopausal
KW  - drug therapy
KW  - Pelvic Bones
KW  - Risedronic Acid
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00198-007-0531-9
ER  -